Gastroenterology News

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.

From 2002 to 2021, the incidence rate of alcohol-associated hepatitis “more than doubled” among adolescents and young adults in Ontario, Canada, with the highest uptick observed among females, according to research in JAMA Network Open.

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory bowel disease, Lilly reported.

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including hypertension, chronic kidney disease and gastrointestinal bleeding, noted a study published in Arthritis Care & Research.

As physicians, we have all borne witness to patients dying at a young age, whether from an unforeseen illness or injury.

Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, with researchers suggesting the recommended 10-year rescreening interval may be extended for this population.

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data.

The noncompete ban issued by the Federal Trade Commission emerged as one of the most talked about employment law issues in 2024 affecting workers, including medical professionals.

This month’s Healio Exclusive highlights an essential dialogue on gender disparities in medicine, particularly in gastroenterology, and the persistent barriers women face in achieving leadership roles.